Better Buy: Abbott Laboratories vs. AbbVie

You'd have to rank Abbott Laboratories' (NYSE: ABT) spin-off of AbbVie (NYSE: ABBV) in 2013 as one of the best corporate moves of the last decade. Since the separation, Abbott's share price has soared 184%, while AbbVie stock is up 158%.

Which stock is the better pick now for long-term investors? Here's how Abbott and AbbVie stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com